Sharath Reddy Venna
Global Regulatory Operations Leader | Expert in Regulatory Informatics & Compliance Strategy | 17+ Years in Pharma & Biotech
About Sharath
Sharath Reddy Venna is an accomplished leader in Global Regulatory Operations, with over 17 years of experience guiding regulatory strategy and operational excellence in the pharmaceutical and biotechnology industries. His career is marked by a consistent track record of driving innovation, enhancing regulatory compliance, and accelerating product approvals across major global markets.
Sharath has led complex submission programs across the United States (FDA), Europe (EMA), Canada (Health Canada), and other international regulatory agencies. His expertise spans the full spectrum of regulatory operations, including eCTD publishing, submission lifecycle management, document management systems (DMS), and compliance tracking frameworks.
Industry Impact
A pioneer in regulatory informatics, Sharath has implemented advanced technology solutions to improve submission accuracy, efficiency, and speed. Under his leadership, global regulatory teams have adopted streamlined processes that consistently meet or exceed regulatory expectations. His initiatives have directly contributed to:
-
Improved first-cycle approval rates
-
Significant reductions in submission timelines
-
Enhanced global regulatory alignment and transparency
Sharath has also been instrumental in establishing governance models for regulatory data quality, GxP compliance, and submission analytics, positioning companies for long-term success in both emerging and mature markets.
Leadership & Vision
Beyond technical proficiency, Sharath is recognized for his strategic thinking and collaborative leadership style. He has led cross-functional teams through regulatory transformations, ensuring agility, risk mitigation, and operational resilience in today’s dynamic regulatory environment.
His thought leadership is evident in his ability to connect compliance strategies with broader business goals—supporting everything from breakthrough therapy designations to global market expansion. Sharath’s commitment to operational excellence continues to set new benchmarks in the field.